MorphoSys AG
MOR · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $2,536 | $1,419 | $868 | $936 |
| - Cash | $131 | $159 | $188 | $184 |
| + Debt | $261 | $636 | $283 | $281 |
| Enterprise Value | $2,665 | $1,896 | $963 | $1,032 |
| Revenue | $28 | $59 | $64 | $53 |
| % Growth | -53.4% | -7.4% | 20% | – |
| Gross Profit | $24 | $45 | $49 | $45 |
| % Margin | 86% | 75.4% | 76.3% | 85.5% |
| EBITDA | -$307 | $52 | -$51 | -$43 |
| % Margin | -1,115.8% | 88.5% | -79.8% | -80.3% |
| Net Income | -$315 | $48 | -$120 | -$74 |
| % Margin | -1,143.7% | 81.7% | -187.5% | -139.1% |
| EPS Diluted | -2.07 | 0.31 | -0.87 | -0.54 |
| % Growth | -767.7% | 135.6% | -61.1% | – |
| Operating Cash Flow | -$64 | -$56 | -$34 | -$126 |
| Capital Expenditures | -$0 | -$1 | -$2 | -$0 |
| Free Cash Flow | -$64 | -$57 | -$35 | -$126 |